Make Yourself a Master in Aortic Valve Disease Care

A day and a half in New York City in December can bring you fully up to speed on all the latest in aortic valve disease management.

That’s the aim of “Mastering the Management of Aortic Valve Disease: A Case-Based Approach,” a Cleveland Clinic-directed live CME program running from Friday morning, Dec. 13, to midday Saturday, Dec. 14, 2019. The course will be held at JW Marriott Essex House New York, adjacent to Central Park.

“For the past two years we’ve offered a very popular CME event called ‘Mastering the Mitral Valve’ at this same venue in New York City on a weekend in early December,” says course co-director Lars Svensson, MD, PhD, Chair of Cleveland Clinic’s Miller Family Heart & Vascular Institute. “This year we decided to mix things up a bit by taking the same approach but applying it to the latest in aortic valve disease care.”

The course does so with a dynamic lineup of topics across five broad sessions focusing on the following areas:

• A Contemporary Framework for Approaching Aortic Valve Disease in 2019. This session explores subjects ranging from the evolution of the aortic valve center to current guidelines on when and how to intervene to whether there’s a role for medical therapy in aortic valve disease.
• Imaging of the Aortic Valve — From Basic to Advanced Techniques. A series of six 15-minute case presentations illustrates the role of various imaging modalities in diverse clinical contexts, including several different presentations of aortic stenosis, a case of workup for transcatheter aortic valve replacement (TAVR), severe aortic regurgitation, and bicuspid aortic valve with aortopathy.
• Controversies and Difficult Scenarios in Aortic Valve Disease. This session fills all of Friday afternoon’s agenda with exploration of 11 clinical challenges such as the choice between valve-in-valve TAVR and redo surgery, surgical aortic valve replacement (SAVR) versus TAVR in the setting of radiation heart disease, and management of acute aortic regurgitation due to aortic dissection.
• TAVR. Saturday kicks off with a session of 13 rapid-fire, 10-minute presentations on all the latest issues in TAVR therapy, including various explorations of its use in low-risk patients, cerebral protection, when to perform balloon valvuloplasty, and endocarditis after TAVR.
• Emerging Technologies. This concluding session, which is not certified for CME credit, provides updates on a range of new devices for treatment of aortic valve disease — including accessory devices and wearable technology — presented by leading experts in their development and testing.

Sessions are briskly paced with well-focused presentations of 10 to 20 minutes, and all are punctuated with panel discussions and Q&A periods where attendees can interact with the 19 expert faculty from Cleveland Clinic and four other leading U.S. medical centers.

“Like the last offering of our ‘Mastering the Mitral Valve’ course, this program takes a decidedly case-based approach, with many presenters sharing their insights through practical application in real-world clinical scenarios,” notes Dr. Svensson.

“Cardiologists, interventionalists, cardiac surgeons and others involved in the care of patients with aortic valve disease will leave this course equipped to apply the latest insights from clinical trials and registry studies to their practice, from considerations surrounding TAVR in low-risk patients to best practices in patient assessment,” he adds.

Visit ccfcme.org/aorticmasters for registration and more details. Early-bird registration pricing ends Oct. 7.

This activity has been approved for AMA PRA Category 1 Credit™.